P

Inventor

ZHAO WEI-QIN

US8 patents
⚠️ This page may combine multiple inventors who share the name “ZHAO WEI-QIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ACUMEN PHARMACEUTICALS INC

3 patents
US7964359B2Jun 21, 2011

Compositions and methods for the enhancement of soluble amyloid beta oligomer (ADDL) uptake and clearance

ACUMEN PHARMACEUTICALS INC0 citations48
US9320793B2Apr 26, 2016

Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42

ACUMEN PHARMACEUTICALS INC1 citations45
US9310383B2Apr 12, 2016

Antibodies, kit and method for detecting amyloid beta oligomers

ACUMEN PHARMACEUTICALS INC1 citations44

US HEALTH

1 patent
US6552053B2Apr 22, 2003

Controlling attention and memory by altering neuronal carbonic anhydrase activity

US HEALTH24 citations90

BRNI NEUROSCIENCES INST

1 patent
US7682807B2Mar 23, 2010

Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation

BRNI NEUROSCIENCES INST6 citations72

MERCK SHARP & DOHME

1 patent
US9309309B2Apr 12, 2016

Anti-ADDL monoclonal antibody and uses thereof

MERCK SHARP & DOHME3 citations69

ZHAO WEI-QIN

1 patent
US9188595B2Nov 17, 2015

Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation

ZHAO WEI-QIN5 citations67

GOURE WILLIAM F

1 patent
US9176151B2Nov 3, 2015

Antibodies, kit and method for detecting amyloid beta oligomers

GOURE WILLIAM F0 citations37